Dolutegravir Resistance and Failure in a Kenyan Patient
Author:
Affiliation:
1. Department of Clinical Medicine and Therapeutics, University of Nairobi, Kenya
2. Institute of Human Virology and Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Link
http://academic.oup.com/jid/article-pdf/219/1/165/27053605/jiy436.pdf
Reference14 articles.
1. The S230R integrase substitution associated with virus load rebound during dolutegravir monotherapy confers low-level resistance to integrase strand-transfer inhibitors;Pham;J Infect Dis,2018
2. HIV-1 resistance dynamics in patients with virologic failure dolutegravir maintenance monotherapy;Wijting;J Infect Dis,2018
3. Resistance to dolutegravir--a chink in the armor;Kuritzkes;J Infect Dis,2018
4. Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance;Malet;J Antimicrob Chemother,2015
5. High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen;Cavalcanti;J Antimicrob Chemother,2015
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevalence and factors associated with suboptimal adherence to dolutegravir-based regimens among people living with HIV in a specialized clinic in Kampala, Uganda;2023-11-01
2. New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?;FEMS Microbiology Reviews;2022-09-20
3. First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens;Antimicrobial Resistance & Infection Control;2020-08-26
4. Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples;PLOS ONE;2019-11-21
5. An Evolutionary Model-Based Approach To Quantify the Genetic Barrier to Drug Resistance in Fast-Evolving Viruses and Its Application to HIV-1 Subtypes and Integrase Inhibitors;Antimicrobial Agents and Chemotherapy;2019-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3